TickerFacts.

NRC Health (NRC): Cash & Equivalents

Annual figures by period end, from SEC filings.

$4.14M
As of 2025-12-31
$3.33M
As of 2026-06-30
-45.1%
3-year compound annual growth
-34.6%
5-year compound annual growth
-20.7%
10-year compound annual growth
$54.36M2009-12-31: $2.51M2010-12-31: $3.52M2011-12-31: $8.08M2012-12-31: $8.29M2013-12-31: $22.09M2014-12-31: $40.04M2015-12-31: $42.15M2016-12-31: $33.02M2017-12-31: $34.73M2018-12-31: $12.99M2019-12-31: $13.52M2020-12-31: $34.69M2021-12-31: $54.36M2022-12-31: $25.03M2023-12-31: $6.65M2024-12-31: $4.23M2025-12-31: $4.14M$4.14M
2009-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$4.14M-2.2%2026-03-05, Balance as of period end
2024-12-31$4.23M-36.4%2026-03-05, Balance as of period end
2023-12-31$6.65M-73.4%2025-03-17, Balance as of period end
2022-12-31$25.03M-54.0%2024-02-27, Balance as of period end
2021-12-31$54.36M+56.7%2023-03-03, Balance as of period end
2020-12-31$34.69M+156.6%2022-03-04, Balance as of period end
2019-12-31$13.52M+4.0%2021-03-05, Balance as of period end
2018-12-31$12.99M-62.6%2020-03-06, Balance as of period end
2017-12-31$34.73M+5.2%2020-03-06, Balance as of period end
2016-12-31$33.02M-21.6%2019-03-08, Balance as of period end
2015-12-31$42.15M+5.3%2018-03-14, Balance as of period end
2014-12-31$40.04M+81.3%2017-03-03, Balance as of period end
2013-12-31$22.09M+166.6%2016-03-04, Balance as of period end
2012-12-31$8.29M+2.5%2015-03-04, Balance as of period end
2011-12-31$8.08M+129.7%2014-03-04, Balance as of period end
2010-12-31$3.52M+40.1%2014-03-04, Balance as of period end
2009-12-31$2.51Mn/a2012-03-01, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
NRC Health (NRC)2025-12-31$4.14M-2.2%
MaxCyte, Inc. (MXCT)2025-12-31$20.07M-28.0%
OmniAb, Inc. (OABI)2025-12-31$25.52M-7.5%
Foxo Technologies Inc. (FOXO)2025-12-31$207.5K+203.9%
Medpace Holdings, Inc. (MEDP)2025-12-31$497.05M-25.8%
bioAffinity Technologies, Inc. (BIAF)2025-12-31$6.45M+483.5%
Charles River Laboratories International, Inc. (CRL)2025-12-27$213.77M+9.8%
Incyte Corp (INCY)2025-12-31$3.10B+83.5%
Absci Corp (ABSI)2025-12-31$20.02M-51.4%

Compare NRC, MXCT, OABI, FOXO side by side · Screen every company in Services-Commercial Physical & Biological Research ↗